RenovoRx, Inc. RNXT

1.66 (0.02) (1.19%) as of 25 Sep
Market cap
$75.8M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Dec '17 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
— — — — — — 0.00 0.00
P/S ratio
— — — — — — 0.00 26.43
P/FCF ratio
— — — — — — 0.00 0.00
P/Operating CF
— — — — — — (11.82) (9.83)
P/B ratio
— — — — — — 6.42 5.47
Price to Tangible BV
— — — — — — 6.42 5.47
EV/Sales
— — — — — — 0.00 24.45
EV/EBITDA
— — — — — — 0.00 0.00
EV/Operating CF
— — — — — — (2.89) (2.50)
EV/FCF
— — — — — — (2.88) (2.50)
Quick Ratio
— 2.64 0.44 16.20 5.84 1.00 3.77 3.65
Current Ratio
— 2.81 0.47 17.36 6.59 1.25 4.10 4.02
Net Debt/EBITDA
— (2.64) (0.32) 3.06 0.65 0.10 0.65 0.56
Debt/Assets
0.00% 545.86% 139.66% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt/Equity
— (1.13) (0.18) 0.00 0.00 0.00 0.00 0.00
Asset Turnover
— 0.00 0.00 0.00 0.00 0.00 0.01 0.14
Operating CF/Net income
— 0.87 0.93 0.94 0.89 1.00 1.04 0.98
Capex/Depreciation
— — 0.00 (0.02) 0.00 — 0.00 (1.00)
Interest Coverage
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
— 30.01% 29.69% (1,825.11%) (91.94%) (646.98%) (1,192.69%) (225.62%)
ROA
— (338.24%) (181.55%) (69.49%) (83.98%) (234.38%) (183.93%) (137.77%)
ROIC
— 0.00% 0.00% (2,257.56%) 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
— (262.77%) 173.74% (41.20%) (160.46%) (3,516.15%) (148.61%) (187.92%)
Average Days of Receivables
— — — — — — 365.00 45.18
Research and Development Expense of Revenue
— 0.00% 0.00% 0.00% 0.00% 0.00% 14,011.63% 558.24%
Selling, General and Administrative Expense of Revenue
— 0.00% 0.00% 0.00% 0.00% 0.00% 11,600.00% 626.63%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
— 0.00% 0.00% 0.00% 0.00% 0.00% 2,730.23% 112.82%
Graham Net Nets
— — — — — — 0.15 0.18
Graham Number
— — — — — — 0.00 0.00
Earnings Yield
— — — — — — (30.23%) (38.10%)
Free Cash Flow Yield
— — — — — — (31.86%) (36.98%)
Revenue per Share
— 0.00 0.00 0.00 0.00 0.00 0.00 0.03
Operating CF per Share
— (1.54) (1.59) (1.13) (0.97) (1.00) (0.41) (0.31)
Capex per Share
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Free Cash Flow per Share
— (1.54) (1.59) (1.14) (0.97) (1.00) (0.41) (0.31)
Cash per Share
— 0.98 0.81 2.91 0.71 0.11 0.32 0.20
Shareholders Equity per Share
— (5.02) (6.62) 2.94 0.68 (0.29) 0.20 0.15
Interest Debt per Share
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
— (5.02) (6.62) 2.94 0.68 (0.29) 0.20 0.15
Free Cash Flow
— (3.35) (3.53) (5.93) (8.81) (10.26) (9.14) (10.97)
Working Capital
— 1.46 (2.19) 15.34 6.16 0.29 5.92 5.93
Capital Expenditures
— — — (0.01) — — (0.01) 0.00
Net Current Asset Value
— (10.93) (14.66) 15.34 6.16 (3.00) 4.19 5.22
EV/EBIT
— — — — — — 0.00 0.00
Capex to Sales
— — — 0.00 — — 0.28 0.00
Net Profit Margin
— 0.00% 0.00% 0.00% 0.00% 0.00% (20,497.67%) (994.48%)
Price to Operating Income
— — — — — — 0.00 0.00
Other line items
Depreciation/Fixed assets
— — 0.00 117.67 0.00 — 0.00 0.17
Cash ROIC
— (93.34%) 34.63% (19.39%) (69.91%) 561.47% (78.55%) (88.26%)
Accounts Receivable Turnover
— — — — — — 0.00 12.34
Accounts Payable Turnover
— 0.00 0.00 0.03 0.01 0.00 0.00 0.47
Inventory Turnover
— — — 0.00 0.00 — — 0.00
Average Days of Payables
— 0.00 0.00 21,291.67 32,485.00 0.00 0.00 891.85
Days of Inventory on Hand
— — — 0.00 0.00 — — 210.96
Average Receivables
— — — — — — — 0.09
Average Payables
— 0.35 0.35 0.34 0.53 0.55 0.57 0.69
Average Assets
— 1.14 2.09 9.10 11.78 4.37 4.79 8.11
Average Common Equity
— (12.79) (12.79) 0.35 10.76 1.58 0.74 4.95

Fold the line items

Columns are period end dates